BioSpace News Archive

Drug Development

Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.

Innovent Biologics, Inc. announced that the first patient has been successfully dosed in a Phase I clinical trial of anti-cluster of differentiation 47 monoclonal antibody drug candidate in the United States.

March 18, 2019
·
5 min read
Shineco, Inc. Establishes Subsidiary to Capture Industrial Cannabis Market Growth

Shineco, Inc. announced that the Company has established a wholly owned subsidiary, Beijing Tenjove Newhemp Biotechnology Co., Ltd. on March 13, 2019, to capture growth in the industrial cannabis market.

March 18, 2019
·
3 min read
FDA

FDA Approves Genentech’s Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer

Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC)

March 18, 2019
·
13 min read
Business

CORRECTING and REPLACING Bioceres Crop Solutions Corp. Reports Financial Results for the Second Quarter and First Half Ended December 31, 2018

On March 14, 2019, Bioceres LLC and Union Acquisition Corp. successfully completed the previously announced business combination.

March 18, 2019
·
18 min read
Deals

Alcon Acquires PowerVision for $285 Million

Alcon said the acquisition of PowerVision demonstrates its commitment to bringing advanced technology intraocular lenses to cataract patients across the globe.

March 18, 2019
·
2 min read
·
Alex Keown
Business

Is It Alzheimer’s or Some Other Type of Dementia? The Diagnosis Matters.

Within the non-medical community, there is a tendency to just refer to dementia and Alzheimer’s interchangeably, but the Alzheimer’s Disease-Related Dementias Summit 2019 emphasized that physicians need to make the distinction for best patient care.

March 18, 2019
·
3 min read
·
Mark Terry
Business

Karuna Snags $68 Million to Support Schizophrenia Treatment Development

The latest financing round will boost the study of KarXT, Karuna’s lead product candidate, which is currently in Phase II development as a potential treatment for acute psychosis in patients with schizophrenia.

March 18, 2019
·
2 min read
·
Alex Keown
BioForest

Women’s History Month: 10 Women Biopharma Pioneers

March is Women’s History Month, with March 8 designated as International Women’s Day. Let’s take a look at 10 pioneers, some still alive, and some who are no longer with us, who are pioneers in the field of biotechnology.

March 18, 2019
·
7 min read
·
Mark Terry
Biotech Bay

ACC Roundup: Less Aspirin to Prevent Heart Attacks, Bristol-Myers & Pfizer, Apple Watch and More

The American College of Cardiology (ACC) annual meeting was held this weekend in New Orleans. Here’s a look at some of the top stories that came out of the meeting.

March 18, 2019
·
4 min read
·
Mark Terry
Drug Development

Dermira Skyrockets on Positive Phase II Results for Atopic Dermatitis Treatment

The stock is up more than 100 percent after the company announced positive results from a Phase IIb study of lebrikizumab, an investigational therapy, in adult patients with moderate-to-severe atopic dermatitis.

March 18, 2019
·
2 min read
·
Alex Keown